ORP-5, or Oxysterol-binding protein-related protein 5, serves a crucial role within the cellular lipid management framework, predominantly by regulating the transfer and signaling of lipids such as cholesterol and phospholipids between cellular compartments. This protein's activity is instrumental in maintaining the integrity and dynamic nature of cell membranes, facilitating proper cell function and survival. ORP-5 is part of a larger family of lipid transfer proteins that possess the ability to bind and transport multiple lipid species across the intracellular space, particularly at membrane contact sites. These sites are critical junctions where the membranes of different organelles are closely apposed to facilitate the exchange of lipids and ions. The functionality of ORP-5 in these regions is essential for coordinating lipid signals that govern cellular metabolism, signaling pathways, and membrane composition adjustments in response to changing cellular needs.
The activation of ORP-5 is a finely tuned process influenced by several factors that ensure its operation is timely and contextually appropriate. Primarily, the activation of ORP-5 is believed to be modulated by the binding of specific lipids to its oxysterol-binding domain, which induces conformational changes that may enhance its affinity for other lipid species or alter its interaction with other proteins at the membrane contact sites. This lipid-induced activation is a critical step that enables ORP-5 to function as a lipid sensor and mediator, adjusting the distribution of lipids according to cellular requirements. Moreover, phosphorylation states can also play a significant role in regulating ORP-5 activity. Specific kinases and phosphatases may target ORP-5, modifying its phosphorylation pattern, which could potentially influence its lipid binding capacity, its interaction with other cellular proteins, and its ability to translocate between different cellular compartments. These post-translational modifications are crucial for adapting ORP-5's activity in response to various cellular signals and stresses, thereby maintaining lipid homeostasis and supporting overall cellular health. Through these mechanisms, ORP-5 ensures that lipid metabolism and signaling are precisely regulated, providing flexibility and resilience to cells under diverse physiological conditions.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $118.00 $320.00 $622.00 $928.00 $1234.00 | 38 | |
PPARγ activator which affects lipid homeostasis. Activation of PPARγ can influence cellular cholesterol levels, indirectly affecting ORP-5's role in cholesterol trafficking. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $54.00 $123.00 | 13 | |
Another PPARγ activator, it impacts lipid metabolism. By changing lipid content within cells, ORP-5's lipid transfer capabilities can be indirectly modulated. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $28.00 $88.00 $332.00 | 12 | |
HMG-CoA reductase inhibitor, altering cholesterol synthesis. Reduced intracellular cholesterol synthesis can prompt ORP-5 to compensate by enhancing lipid transport. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $60.00 $270.00 $350.00 | 48 | |
AMPK activator that impacts cellular energy and lipid metabolism. By modulating lipid pathways, ORP-5's lipid transport functions can be influenced. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $162.00 $316.00 $559.00 $889.00 $1693.00 | 7 | |
A lipid signaling molecule influencing various cellular processes, including lipid trafficking, potentially affecting ORP-5's function in lipid transport. | ||||||
GW 3965 hydrochloride | 405911-17-3 | sc-224011 sc-224011A sc-224011B | 5 mg 25 mg 1 g | $137.00 $474.00 $3060.00 | ||
LXR agonist that regulates cholesterol homeostasis. Activation can alter intracellular cholesterol distribution, indirectly influencing ORP-5's role in cholesterol transport. | ||||||
T 0901317 | 293754-55-9 | sc-202824 sc-202824A | 10 mg 50 mg | $87.00 $220.00 | 5 | |
Another LXR agonist that modulates cholesterol metabolism. By affecting cholesterol homeostasis, ORP-5's lipid trafficking activity can be indirectly modulated. | ||||||
Probucol | 23288-49-5 | sc-203666 sc-203666A | 100 mg 1 g | $77.00 $163.00 | 5 | |
Antioxidant that reduces cellular cholesterol levels. Decreased cholesterol can affect ORP-5's role in lipid transfer and trafficking. | ||||||
Clofibrate | 637-07-0 | sc-200721 | 1 g | $32.00 | ||
PPARα agonist affecting lipid metabolism. By modulating intracellular lipid content, ORP-5's lipid trafficking functions can be indirectly influenced. | ||||||
Cilostazol | 73963-72-1 | sc-201182 sc-201182A | 10 mg 50 mg | $107.00 $316.00 | 3 | |
Phosphodiesterase inhibitor impacting lipid metabolism. By altering lipid levels, it indirectly modulates ORP-5's role in lipid transport. | ||||||